Schizophrenia is a chronic, severe and disabling psychiatric disorder that affects about one percent of the population in the United States. Approximately 60 percent of those suffering from this ...

Joshua Kaufman, MD, of CDPHP, discusses the significance of long-acting injectables (LAIs) in improving adherence, reducing the risk of relapse, and preventing hospitalizations. If a patient has a ...

When I was first diagnosed with schizoaffective disorder in 2017, none of my existing doctors or therapists specialized in schizophrenia disorders. I had a really hard time finding therapies that ...

Schizophrenia is a chronic psychiatric disorder that requires lifelong management, with consistent medication adherence essential to prevent relapse and disability. Counseling that emphasizes empathy, ...

FDA approves evidence-based tool (Bysanti) to address severe mood and psychotic symptoms, which may predict future indications.